Maximum Standardized Uptake Value and Cell-Free DNA to Predict Adjuvant Therapy in Resectable NonSmall Cell Lung Cancer

被引：0
|
作者：
Azkona Uribelarrea, E. [1 ]
Aurrekoetxea Oribe, J. [1 ]
Portilla-Quattrociocchi, H. [1 ]
Casas, R. [1 ]
Ortega Gallastegi, B. [1 ]
Calvo Martinez, M. B. [1 ]
机构：
[1] Cruces Univ Hosp, Baracaldo, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
maxSUV; cfDNA; adjuvant therapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP.07G.05
引用
收藏
页码：S561 / S561
页数：1
相关论文
共 50 条
  • [21] Targeted therapy in nonsmall cell lung cancer
    Puri, T.
    INDIAN JOURNAL OF CANCER, 2017, 54 (01) : 83 - 88
  • [22] Cell-free DNA as a predictive and prognostic marker in adjuvant-treated non-small cell lung cancer
    Azkona, E.
    Casas, R.
    Aurrekoetxea, J.
    De Elejoste Echebarria, I.
    Fernandez, M.
    Sagarduy, J. Azcuna
    Garcia, L.
    Saiz, M.
    Gallastegi, B. Ortega
    Calvo, B.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S93 - S93
  • [23] Chemoradiation therapy in nonsmall cell lung cancer
    Baas, Paul
    Belderbos, Jose S. A.
    van den Heuvel, Michel
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (02) : 140 - 149
  • [24] Cell-free Circulating DNA: Diagnostic Value in Patients with Renal Cell Cancer
    Hauser, Stefan
    Zahalka, Tobias
    Ellinger, Joerg
    Fechner, Guido
    Heukamp, Lukas C.
    Von Ruecker, Alexander
    Mueller, Stefan C.
    Bastian, Patrick J.
    ANTICANCER RESEARCH, 2010, 30 (07) : 2785 - 2789
  • [25] Immunotherapy in patients with early stage resectable nonsmall cell lung cancer
    Ghysen, Katrien
    Vansteenkiste, Johan
    CURRENT OPINION IN ONCOLOGY, 2019, 31 (01) : 13 - 17
  • [26] Dissecting small cell lung cancer subtypes with cell-free DNA fragmentomes
    Rinaldi, Lorenzo
    Skidmore, Zachary L.
    Alipanahi, Bahar
    Graham, Garrett
    Chesnick, Bryan
    Takahashi, Nobuyuki
    Kumar, Rajesh
    Goyal, Shubhank
    Abel, Melissa Lauren
    Malin, Justin
    Desai, Parth Anil
    Dracopoli, Nicholas C.
    Velculescu, Victor E.
    Thomas, Anish
    Leal, Alessandro
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Circulating cell-free DNA: a potential biomarker in lung cancer
    Taylor, Fiona
    Teare, M. Dawn
    Cox, Angela
    Woll, Penella J.
    LUNG CANCER MANAGEMENT, 2013, 2 (05) : 407 - 422
  • [28] Cell-free DNA methylation in the clinical management of lung cancer
    Ezegbogu, Mark
    Wilkinson, Emma
    Reid, Glen
    Rodger, Euan J.
    Brockway, Ben
    Russell-Camp, Takiwai
    Kumar, Rajiv
    Chatterjee, Aniruddha
    TRENDS IN MOLECULAR MEDICINE, 2024, 30 (05) : 499 - 515
  • [29] Prognostic Value of Tumor-to-Blood Standardized Uptake Ratio in Patients with Resectable Non-Small-Cell Lung Cancer
    Shin S.
    Pak K.
    Kim I.J.
    Kim B.S.
    Kim S.J.
    Nuclear Medicine and Molecular Imaging, 2017, 51 (3) : 233 - 239
  • [30] The prognostic value of tumor/lymph node standardized uptake value max ratio and correlation with hematologic parameters in stage III nonsmall cell lung cancer
    Acikgoz, Yusuf
    Gurler, Fatih
    Inci, Bediz Kurt
    Ergun, Yakup
    Ucar, Gokhan
    Dirikoc, Merve
    Esen, Selin Akturk
    Tekin, Berna Okudan
    Bal, Oznur
    Dogan, Mutlu
    Uncu, Dogan
    MEDICINE, 2020, 99 (48) : E23168
12345